Macrogenics (MGNX) Cash from Restructuring (2012 - 2018)
Macrogenics' (MGNX) quarterly Cash from Restructuring came in at -$298000.0 in Q1 2018, up 21.37% year-on-year from -$245526.1 in Q1 2017, and up 28.54% on a QoQ basis from -$417000.0 in Q4 2017.
Macrogenics (MGNX) Cash from Restructuring (2012 - 2018) Analysis & Trends
Macrogenics (MGNX) has 7 years of Cash from Restructuring data on file, last reported at -$298000.0 in Q1 2018.
- On a quarterly basis, Cash from Restructuring rose 21.37% year-over-year to -$298000.0 in Q1 2018; TTM through Mar 2019 was -$298000.0, a 80.29% increase from a year earlier, with the FY2017 full-year figure at -$1.6 million, up 43.55% from the prior year.
- Cash from Restructuring for Q1 2018 stood at -$298000.0, up from -$417000.0 in the prior quarter.
- Over the last five years, Cash from Restructuring for MGNX reached as high as -$298000.0 in Q1 2018 and fell as low as -$2.0 million in Q2 2015.
- Historically, Cash from Restructuring has averaged -$555588.2 across 5 years, with a median of -$392000.0 in 2017.
- Across the five-year window, Cash from Restructuring slumped 459.72% in 2015 and jumped 76.18% in 2017, its largest moves.
- Year by year, Cash from Restructuring stood at -$372000.0 in 2014, then slipped by 23.66% to -$460000.0 in 2015, then gained by 24.13% to -$349000.0 in 2016, then declined by 19.48% to -$417000.0 in 2017, then advanced by 28.54% to -$298000.0 in 2018.
- Per Business Quant data, the three most recent Cash from Restructuring figures were -$298000.0 in Q1 2018, -$417000.0 in Q4 2017, and -$405000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -298,000.00 |
| Dec 31, 2017 | -417,000.00 |
| Sep 30, 2017 | -405,000.00 |
| Jun 30, 2017 | -392,000.00 |
| Mar 31, 2017 | -379,000.00 |
| Dec 31, 2016 | -349,000.00 |
| Sep 30, 2016 | -339,000.00 |
| Jun 30, 2016 | -1.65 Mn |
| Mar 31, 2016 | -488,000.00 |
| Dec 31, 2015 | -460,000.00 |
| Sep 30, 2015 | -450,000.00 |
| Jun 30, 2015 | -1.99 Mn |
| Mar 31, 2015 | -396,000.00 |
| Dec 31, 2014 | -372,000.00 |
| Sep 30, 2014 | -364,000.00 |
| Jun 30, 2014 | -355,000.00 |
| Mar 31, 2014 | -348,000.00 |
| Dec 31, 2013 | -163,000.00 |
| Sep 30, 2013 | -159,000.00 |
| Jun 30, 2013 | -155,005.00 |